Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-06

Clinical Trial Update: African Cancer Genome: GMD

View source ↗

Summary

The African Cancer Genome: GMD trial, sponsored by Fox Chase Cancer Center, is currently recruiting for breast cancer and prostate cancer indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Fox Chase Cancer Center | Conditions: Breast Cancer, Prostate Cancer | Status: RECRUITING